Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons.
about
Reduced crowding and poor contour detection in schizophrenia are consistent with weak surround inhibitionComputational neuropsychiatry - schizophrenia as a cognitive brain network disorderThe dopamine hypothesis of schizophrenia: version III--the final common pathwayHaloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disordersPerphenazine versus low-potency first-generation antipsychotic drugs for schizophreniaFlupenthixol versus low-potency first-generation antipsychotic drugs for schizophreniaFluphenazine versus low-potency first-generation antipsychotic drugs for schizophreniaHaloperidol versus low-potency first-generation antipsychotic drugs for schizophreniaTrifluoperazine versus low-potency first-generation antipsychotic drugs for schizophreniaHaloperidol versus first generation antipsychotics for schizophreniaFlupenthixol versus low-potency first generation antipsychotic drugs for schizophreniaFluphenazine versus low-potency first generation antipsychotic drugs for schizophreniaHaloperidol versus low-potency first-generation antipsychotic drugs for schizophreniaPerphenazine versus low-potency first generation antipsychotic drugs for schizophreniaTrifluoperazine versus low-potency first generation antipsychotic drugs for schizophreniaHaloperidol versus chlorpromazine for schizophreniaHaloperidol versus chlorpromazine for schizophreniaChemical modulation of mutant mGlu1 receptors derived from deleterious GRM1 mutations found in schizophrenicsBrain receptors for antipsychotic drugs and dopamine: direct binding assaysSynthesis, SAR and unanticipated pharmacological profiles of analogues of the mGluR5 ago-potentiator ADX-47273Phospholipase C-β1 Hypofunction in the Pathogenesis of Schizophrenia.Auditory dysfunction in schizophrenia: integrating clinical and basic features.Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null miceStructural analysis of phenothiazine derivatives as allosteric inhibitors of the MALT1 paracaspaseDrug models of schizophreniaHistory of the discovery of the antipsychotic dopamine D2 receptor: a basis for the dopamine hypothesis of schizophreniaEffect of neuroleptics and other drugs on monoamine uptake by membranes of adrenal chromaffin granulesEffects of methamphetamine administration on information gathering during probabilistic reasoning in healthy humansRole of dysbindin in dopamine receptor trafficking and cortical GABA functionThe antipsychotic potential of muscarinic allosteric modulationCloning of the cDNA and gene for a human D2 dopamine receptorMolecular substrates of schizophrenia: homeostatic signaling to connectivityDeletion of PLCB1 gene in schizophrenia-affected patients.Selective overexpression of dopamine D3 receptors in the striatum disrupts motivation but not cognition.Disruption of dopamine neuron activity pattern regulation through selective expression of a human KCNN3 mutation.Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.Is lead exposure in early life an environmental risk factor for Schizophrenia? Neurobiological connections and testable hypotheses.Activation of GABA(B) receptors inhibits protein kinase B/glycogen synthase kinase 3 signaling.Dexamphetamine selectively increases 40 Hz auditory steady state response power to target and nontarget stimuli in healthy humans.Effects of ketamine on response properties of neurons in the superior paraolivary nucleus of the mouse
P2860
Q21559665-9EC20063-CB97-4327-A8C5-A10EC20A5960Q22241226-6DDCAA69-F7CE-48E8-9B5B-038BC7D3BB01Q22242827-C031AC10-25EC-4B97-965B-272EF7274120Q24186601-9C0A952D-55F3-4B8D-AF7E-FDC70C3E9D66Q24193168-A8164BEF-10E5-410C-A9A6-0A5BB497C77BQ24193881-ACD1DEBA-EC27-4CAD-944E-E3D7F5AB914EQ24194501-9648C87D-A5BA-4D0B-9C2B-D55E51D561EDQ24194891-D9503BA1-5DA4-4817-BBF8-89DAB876468CQ24194898-B33749AA-9FA7-4DDA-8906-28CABDE89B21Q24198264-65380CDA-B3F7-4F51-8B08-7BB4F06280C2Q24235116-21289E5C-0B2D-4E14-9CA4-3FD3364B2395Q24235274-CB02C66B-B809-4879-B4A0-396EE271BF63Q24235300-6E1E0197-DC98-469C-BE4D-95AEAF92B850Q24236586-C5A630A4-4B74-4F8F-A30A-DE1950555C0DQ24236681-F427C7B4-B181-46F0-8208-873EB7C75308Q24242553-E0309384-FA7C-463D-B6EB-EF1665AB53C0Q24248139-16066E7C-6DFD-440B-9052-FCC83B4B3EF2Q24561726-F1E78A63-23AD-425D-80E7-FF11D2E74B1CQ24619577-E240BBE5-D6E6-41CC-B792-3B08DD930A76Q24626912-46BB0FBB-D5CC-449A-9A9E-8CB206BE0B25Q26774767-D640176C-CFC1-41E8-999E-213EE284EAE6Q26796401-6E38AD4B-1D88-4BF1-B588-7A22C52015A3Q27324246-13F1F5DD-9A70-403C-BCD8-7289F21925DEQ27685382-1705019A-7C9F-4D34-8B05-DEDFB1083FADQ28084198-A65A9985-1D7C-4FFE-A1BD-A9C60A0C5272Q28283494-A9110215-DE26-4E21-A26F-2FDF9F0A24E1Q28330782-2B6D29EB-5B9D-49FA-BC6C-B0DB2D9B205CQ28541201-9B54013F-88DF-4CDD-AF85-172BCC966251Q28593127-DD35EB35-E9BF-4F13-A7C4-83DC9E51FB08Q28603221-E32887AE-23BB-45D6-8D7F-9F897A917B77Q28645687-FBB26C5D-AE66-46F2-993F-16D1C298872BQ30383611-0F4385AE-ABB4-4188-A4C4-D9E794CDA490Q30415884-B740EFE9-152F-421F-8838-BE8AA3FCBE0BQ30423688-78998866-00A8-421B-8032-CFDF2C73BD62Q30425716-20824AF5-B34C-4ACB-BD3D-B960C521D502Q30428213-131F1EC7-EFBE-4C1B-B240-8F5D9B9C7168Q30454141-3B5AE77B-D6B6-4B90-8F5D-EC6CFC993120Q30458968-657302C9-912C-440E-90AA-5DB976FB42D7Q30459202-ECA23244-9F79-4919-82FD-AAE79EFE5E79Q30459205-343DEF8F-2357-4BEC-896B-B18174AED95F
P2860
Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
1975年论文
@zh
1975年论文
@zh-cn
name
Antipsychotic drugs: direct co ...... ic action on dopamine neurons.
@en
type
label
Antipsychotic drugs: direct co ...... ic action on dopamine neurons.
@en
prefLabel
Antipsychotic drugs: direct co ...... ic action on dopamine neurons.
@en
P356
P1433
P1476
Antipsychotic drugs: direct co ...... ic action on dopamine neurons.
@en
P304
P356
10.1126/SCIENCE.1145194
P407
P577
1975-06-01T00:00:00Z